Top in cardiology: Treating excess weight; hypertension ‘phenomenon’
For patients with obesity, physicians should first treat excess weight when addressing underlying cardiometabolic disease, according to a speaker at the Cardiometabolic Health Congress.
“It is very clear that developments in the field of obesity research are going to completely change the way we treat cardiometabolic disease,” Louis J. Aronne, MD, FACP, FTOS, DABOM, said in the presentation. It was the top story in cardiology last week.

The second top story was about the “real phenomenon” of masked hypertension and the efforts that can be made to improve outcomes, such as home BP monitoring and stepped-up medications, according to Raymond R. Townsend, MD, FAHA. He explained how masked hypertension can present itself in different patients during the Cardiometabolic Health Congress.
Read these and more top stories in cardiology below:
In obesity, treat excess weight first to address underlying cardiometabolic disease
New drugs and devices can reduce weight and weight-related comorbidities, and physicians should optimize therapy choices for patients with several common conditions to reduce their cardiometabolic risk, according to a speaker. Read more.
Masked hypertension ‘real phenomenon’ driving cardiometabolic risk
Masked hypertension is an underappreciated phenomenon that confers extra risk for CVD and chronic kidney disease, and simple steps such as home BP monitoring and stepped-up medications can improve outcomes, according to a speaker. Read more.
COVID-19 confers risk for death, CV events, especially in hospitalized patients
Compared with uninfected controls, patients hospitalized for COVID-19 had elevated risk for death and cardiovascular events, according to new data from the UK Biobank. Read more.
Residual CVD risk varies; individualized treatments best to combat it
The medical community is better equipped to combat residual CVD risk than previously, but prevention of residual risk should be tailored using a precision medicine approach, a speaker said at the Cardiometabolic Health Congress. Read more.
Poor food environment, food insecurity linked to higher HF mortality in US
Food environment may play a significant role in the county-level rate of heart failure mortality in the U.S., according to a study published in Circulation: Heart Failure. Read more.